カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場予測2023-2029：AMG-228、BMS-986156、FPA-154、GWN-323、INCAGN-1876、その他

【英語タイトル】Tumor Necrosis Factor Receptor Superfamily Member 18 Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8726）・商品コード：MMG23LY8726
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：74
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場規模と予測を収録しています。・世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場：売上、2018年-2023年、2024年-2029年
・世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「AMG-228」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

腫瘍壊死因子受容体スーパーファミリーメンバー18のグローバル主要企業は、Ablynx NV、 Amgen Inc、 Apogenix GmbH、 Bristol-Myers Squibb Company、 Five Prime Therapeutics Inc、 Incyte Corp、 MedImmune LLC、 Merck & Co Inc、 Novartis AG、 OncoMed Pharmaceuticals Inc、 Regeneron Pharmaceuticals Incなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、腫瘍壊死因子受容体スーパーファミリーメンバー18のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場：タイプ別、2018年-2023年、2024年-2029年
世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場：タイプ別市場シェア、2022年
・AMG-228、BMS-986156、FPA-154、GWN-323、INCAGN-1876、その他

世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場：用途別、2018年-2023年、2024年-2029年
世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場：用途別市場シェア、2022年
・黒色腫、非小細胞肺がん、胃がん、血液がん、その他

世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場：地域・国別、2018年-2023年、2024年-2029年
世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における腫瘍壊死因子受容体スーパーファミリーメンバー18のグローバル売上、2018年-2023年
・主要企業における腫瘍壊死因子受容体スーパーファミリーメンバー18のグローバル売上シェア、2022年
・主要企業における腫瘍壊死因子受容体スーパーファミリーメンバー18のグローバル販売量、2018年-2023年
・主要企業における腫瘍壊死因子受容体スーパーファミリーメンバー18のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Ablynx NV、 Amgen Inc、 Apogenix GmbH、 Bristol-Myers Squibb Company、 Five Prime Therapeutics Inc、 Incyte Corp、 MedImmune LLC、 Merck & Co Inc、 Novartis AG、 OncoMed Pharmaceuticals Inc、 Regeneron Pharmaceuticals Inc

*************************************************************

・調査・分析レポートの概要
腫瘍壊死因子受容体スーパーファミリーメンバー18市場の定義
市場セグメント
世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場規模
世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場規模：2022年 VS 2029年
世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの腫瘍壊死因子受容体スーパーファミリーメンバー18の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の腫瘍壊死因子受容体スーパーファミリーメンバー18製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：AMG-228、BMS-986156、FPA-154、GWN-323、INCAGN-1876、その他
腫瘍壊死因子受容体スーパーファミリーメンバー18のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：黒色腫、非小細胞肺がん、胃がん、血液がん、その他
腫瘍壊死因子受容体スーパーファミリーメンバー18の用途別グローバル売上・予測

・地域別市場分析
地域別腫瘍壊死因子受容体スーパーファミリーメンバー18市場規模 2022年と2029年
地域別腫瘍壊死因子受容体スーパーファミリーメンバー18売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Ablynx NV、 Amgen Inc、 Apogenix GmbH、 Bristol-Myers Squibb Company、 Five Prime Therapeutics Inc、 Incyte Corp、 MedImmune LLC、 Merck & Co Inc、 Novartis AG、 OncoMed Pharmaceuticals Inc、 Regeneron Pharmaceuticals Inc
...

This report aims to provide a comprehensive presentation of the global market for Tumor Necrosis Factor Receptor Superfamily Member 18, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Necrosis Factor Receptor Superfamily Member 18. This report contains market size and forecasts of Tumor Necrosis Factor Receptor Superfamily Member 18 in global, including the following market information:
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Tumor Necrosis Factor Receptor Superfamily Member 18 companies in 2022 (%)
The global Tumor Necrosis Factor Receptor Superfamily Member 18 market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
AMG-228 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 18 include Ablynx NV, Amgen Inc, Apogenix GmbH, Bristol-Myers Squibb Company, Five Prime Therapeutics Inc, Incyte Corp, MedImmune LLC, Merck & Co Inc and Novartis AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tumor Necrosis Factor Receptor Superfamily Member 18 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Segment Percentages, by Type, 2022 (%)
AMG-228
BMS-986156
FPA-154
GWN-323
INCAGN-1876
Others
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Segment Percentages, by Application, 2022 (%)
Melanoma
Non-Small Cell Lung Cancer
Gastric Cancer
Blood Cancer
Others
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 revenues share in global market, 2022 (%)
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ablynx NV
Amgen Inc
Apogenix GmbH
Bristol-Myers Squibb Company
Five Prime Therapeutics Inc
Incyte Corp
MedImmune LLC
Merck & Co Inc
Novartis AG
OncoMed Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tumor Necrosis Factor Receptor Superfamily Member 18, market overview.
Chapter 2: Global Tumor Necrosis Factor Receptor Superfamily Member 18 market size in revenue and volume.
Chapter 3: Detailed analysis of Tumor Necrosis Factor Receptor Superfamily Member 18 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tumor Necrosis Factor Receptor Superfamily Member 18 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Tumor Necrosis Factor Receptor Superfamily Member 18 capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Overall Market Size
2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size: 2022 VS 2029
2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales: 2018-2029
3 Company Landscape
3.1 Top Tumor Necrosis Factor Receptor Superfamily Member 18 Players in Global Market
3.2 Top Global Tumor Necrosis Factor Receptor Superfamily Member 18 Companies Ranked by Revenue
3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Companies
3.4 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Companies
3.5 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tumor Necrosis Factor Receptor Superfamily Member 18 Players in Global Market
3.8.1 List of Global Tier 1 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies
3.8.2 List of Global Tier 2 and Tier 3 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Markets, 2022 & 2029
4.1.2 AMG-228
4.1.3 BMS-986156
4.1.4 FPA-154
4.1.5 GWN-323
4.1.6 INCAGN-1876
4.1.7 Others
4.2 By Type – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue & Forecasts
4.2.1 By Type – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2018-2023
4.2.2 By Type – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2024-2029
4.2.3 By Type – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018-2029
4.3 By Type – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales & Forecasts
4.3.1 By Type – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2018-2023
4.3.2 By Type – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2024-2029
4.3.3 By Type – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2018-2029
4.4 By Type – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2022 & 2029
5.1.2 Melanoma
5.1.3 Non-Small Cell Lung Cancer
5.1.4 Gastric Cancer
5.1.5 Blood Cancer
5.1.6 Others
5.2 By Application – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue & Forecasts
5.2.1 By Application – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2018-2023
5.2.2 By Application – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2024-2029
5.2.3 By Application – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018-2029
5.3 By Application – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales & Forecasts
5.3.1 By Application – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2018-2023
5.3.2 By Application – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2024-2029
5.3.3 By Application – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2018-2029
5.4 By Application – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2022 & 2029
6.2 By Region – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue & Forecasts
6.2.1 By Region – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2018-2023
6.2.2 By Region – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2024-2029
6.2.3 By Region – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018-2029
6.3 By Region – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales & Forecasts
6.3.1 By Region – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2018-2023
6.3.2 By Region – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2024-2029
6.3.3 By Region – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2018-2029
6.4.2 By Country – North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2018-2029
6.4.3 US Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.4.4 Canada Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.4.5 Mexico Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2018-2029
6.5.2 By Country – Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2018-2029
6.5.3 Germany Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.5.4 France Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.5.5 U.K. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.5.6 Italy Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.5.7 Russia Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.5.8 Nordic Countries Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.5.9 Benelux Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2018-2029
6.6.2 By Region – Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2018-2029
6.6.3 China Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.6.4 Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.6.5 South Korea Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.6.6 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.6.7 India Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2018-2029
6.7.2 By Country – South America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2018-2029
6.7.3 Brazil Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.7.4 Argentina Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2018-2029
6.8.3 Turkey Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.8.4 Israel Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.8.5 Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
6.8.6 UAE Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Ablynx NV
7.1.1 Ablynx NV Company Summary
7.1.2 Ablynx NV Business Overview
7.1.3 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.1.4 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2018-2023)
7.1.5 Ablynx NV Key News & Latest Developments
7.2 Amgen Inc
7.2.1 Amgen Inc Company Summary
7.2.2 Amgen Inc Business Overview
7.2.3 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.2.4 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Inc Key News & Latest Developments
7.3 Apogenix GmbH
7.3.1 Apogenix GmbH Company Summary
7.3.2 Apogenix GmbH Business Overview
7.3.3 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.3.4 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2018-2023)
7.3.5 Apogenix GmbH Key News & Latest Developments
7.4 Bristol-Myers Squibb Company
7.4.1 Bristol-Myers Squibb Company Company Summary
7.4.2 Bristol-Myers Squibb Company Business Overview
7.4.3 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.4.4 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2018-2023)
7.4.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.5 Five Prime Therapeutics Inc
7.5.1 Five Prime Therapeutics Inc Company Summary
7.5.2 Five Prime Therapeutics Inc Business Overview
7.5.3 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.5.4 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2018-2023)
7.5.5 Five Prime Therapeutics Inc Key News & Latest Developments
7.6 Incyte Corp
7.6.1 Incyte Corp Company Summary
7.6.2 Incyte Corp Business Overview
7.6.3 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.6.4 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2018-2023)
7.6.5 Incyte Corp Key News & Latest Developments
7.7 MedImmune LLC
7.7.1 MedImmune LLC Company Summary
7.7.2 MedImmune LLC Business Overview
7.7.3 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.7.4 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2018-2023)
7.7.5 MedImmune LLC Key News & Latest Developments
7.8 Merck & Co Inc
7.8.1 Merck & Co Inc Company Summary
7.8.2 Merck & Co Inc Business Overview
7.8.3 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.8.4 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2018-2023)
7.8.5 Merck & Co Inc Key News & Latest Developments
7.9 Novartis AG
7.9.1 Novartis AG Company Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.9.4 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2018-2023)
7.9.5 Novartis AG Key News & Latest Developments
7.10 OncoMed Pharmaceuticals Inc
7.10.1 OncoMed Pharmaceuticals Inc Company Summary
7.10.2 OncoMed Pharmaceuticals Inc Business Overview
7.10.3 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.10.4 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2018-2023)
7.10.5 OncoMed Pharmaceuticals Inc Key News & Latest Developments
7.11 Regeneron Pharmaceuticals Inc
7.11.1 Regeneron Pharmaceuticals Inc Company Summary
7.11.2 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Business Overview
7.11.3 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Major Product Offerings
7.11.4 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in Global (2018-2023)
7.11.5 Regeneron Pharmaceuticals Inc Key News & Latest Developments
8 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity, Analysis
8.1 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity, 2018-2029
8.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity of Key Manufacturers in Global Market
8.3 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tumor Necrosis Factor Receptor Superfamily Member 18 Supply Chain Analysis
10.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Industry Value Chain
10.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Upstream Market
10.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Tumor Necrosis Factor Receptor Superfamily Member 18 in Global Market
Table 2. Top Tumor Necrosis Factor Receptor Superfamily Member 18 Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Companies, 2018-2023
Table 5. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
Table 9. List of Global Tier 1 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), 2018-2023
Table 15. By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), 2024-2029
Table 16. By Application – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), 2018-2023
Table 20. By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), 2024-2029
Table 21. By Region – Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), 2018-2023
Table 25. By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), 2024-2029
Table 26. By Country - North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, (K Pcs), 2024-2029
Table 46. Ablynx NV Company Summary
Table 47. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offerings
Table 48. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Ablynx NV Key News & Latest Developments
Table 50. Amgen Inc Company Summary
Table 51. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offerings
Table 52. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Amgen Inc Key News & Latest Developments
Table 54. Apogenix GmbH Company Summary
Table 55. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offerings
Table 56. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Apogenix GmbH Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Company Summary
Table 59. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offerings
Table 60. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Bristol-Myers Squibb Company Key News & Latest Developments
Table 62. Five Prime Therapeutics Inc Company Summary
Table 63. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offerings
Table 64. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Five Prime Therapeutics Inc Key News & Latest Developments
Table 66. Incyte Corp Company Summary
Table 67. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offerings
Table 68. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Incyte Corp Key News & Latest Developments
Table 70. MedImmune LLC Company Summary
Table 71. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offerings
Table 72. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. MedImmune LLC Key News & Latest Developments
Table 74. Merck & Co Inc Company Summary
Table 75. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offerings
Table 76. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Merck & Co Inc Key News & Latest Developments
Table 78. Novartis AG Company Summary
Table 79. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offerings
Table 80. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Novartis AG Key News & Latest Developments
Table 82. OncoMed Pharmaceuticals Inc Company Summary
Table 83. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offerings
Table 84. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. OncoMed Pharmaceuticals Inc Key News & Latest Developments
Table 86. Regeneron Pharmaceuticals Inc Company Summary
Table 87. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Offerings
Table 88. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Regeneron Pharmaceuticals Inc Key News & Latest Developments
Table 90. Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 91. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Production by Region, 2018-2023 (K Pcs)
Table 93. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Production by Region, 2024-2029 (K Pcs)
Table 94. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Opportunities & Trends in Global Market
Table 95. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Drivers in Global Market
Table 96. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Restraints in Global Market
Table 97. Tumor Necrosis Factor Receptor Superfamily Member 18 Raw Materials
Table 98. Tumor Necrosis Factor Receptor Superfamily Member 18 Raw Materials Suppliers in Global Market
Table 99. Typical Tumor Necrosis Factor Receptor Superfamily Member 18 Downstream
Table 100. Tumor Necrosis Factor Receptor Superfamily Member 18 Downstream Clients in Global Market
Table 101. Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Type in 2022
Figure 2. Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Application in 2022
Figure 3. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2018-2029 (US$, Mn)
Figure 7. Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue in 2022
Figure 9. By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018-2029
Figure 11. By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2018-2029
Figure 12. By Type - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018-2029
Figure 15. By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2018-2029
Figure 16. By Application - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018-2029
Figure 20. By Region - Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2018-2029
Figure 21. By Country - North America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018-2029
Figure 22. By Country - North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2018-2029
Figure 23. US Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2018-2029
Figure 28. Germany Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 29. France Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2018-2029
Figure 37. China Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 41. India Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018-2029
Figure 43. By Country - South America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2018-2029
Figure 44. Brazil Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2018-2029
Figure 48. Turkey Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2018-2029
Figure 52. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Tumor Necrosis Factor Receptor Superfamily Member 18 by Region, 2022 VS 2029
Figure 54. Tumor Necrosis Factor Receptor Superfamily Member 18 Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場予測2023-2029：AMG-228、BMS-986156、FPA-154、GWN-323、INCAGN-1876、その他] (コード：MMG23LY8726)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の腫瘍壊死因子受容体スーパーファミリーメンバー18市場予測2023-2029：AMG-228、BMS-986156、FPA-154、GWN-323、INCAGN-1876、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の腫瘍壊死因子受容体スーパーファミリーメンバー1A市場予測2023-2029：LY-3232094、EYS-606、SRT-100、その他
  • 世界の腫瘍壊死因子受容体スーパーファミリーメンバー4市場予測2023-2029：ATOR-1015、ENUM-004、GBR-8383、GSK-3174998、その他
  • 世界の腫瘍壊死因子ガンマ（TNF-γ）ELISAキット市場予測 2023年-2029年
  • 世界の腫瘍壊死因子ガンマ（TNF-γ）ELISAキット市場予測 2023年-2029年
  • 世界のバソプレシンV1b受容体市場予測2023-2029：PHT-103、ABT-436、AVN-628、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆